MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy
- PMID: 16636248
- DOI: 10.1212/01.wnl.0000208958.29600.87
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy
Abstract
Patients with recurrent gliomas (n = 14) were treated with bevacizumab and carboplatin, cpt-11, or etoposide. Follow-up MRI scans were obtained 2 to 6 weeks after initiation of treatment. Contrast-enhancing tumor shrank in 7 patients, with reductions evident in as little as 2 weeks after initiation of therapy. Treatment seemed more effective for heterogeneously enhancing tumor compared with solidly enhancing tumor.
Comment in
-
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy.Neurology. 2006 Dec 12;67(11):2089; author reply 2089. doi: 10.1212/01.wnl.0000250628.10420.d8. Neurology. 2006. PMID: 17159134 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources